Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 260

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 260
---
 consent will not be unreasonably conditioned, withheld, delayed or denied), or set forth in PlusAI’s disclosure letter to the Merger Agreement, PlusAI has agreed to, and to cause its subsidiaries to, use commercially reasonable efforts to operate its business in all material respects in the ordinary course of business.

Subject to specified exceptions and qualifications contained in the Merger Agreement, PlusAI has agreed that neither PlusAI nor any of its subsidiaries will take the following actions during the interim period between signing of the Merger Agreement and Closing without the prior written consent of CCIX (which consent will not be unreasonably conditioned, withheld, delayed or denied):

<div align='center'>148</div>

change or amend PlusAI’s current certificate of incorporation or other organizational documents of PlusAI, except (1) as otherwise required by law, (2) as required in order to effectuate (a) the conversion of PlusAI preferred stock or PlusAI SAFEs into PlusAI common stock or (b) the exercise of PlusAI warrants into PlusAI preferred stock or (3) in connection with a Permitted Equity Financing;

make, declare, set aside, establish a record date for or pay any dividend or distribution, other than any dividends or distributions from any wholly owned subsidiary of PlusAI to PlusAI or any other wholly owned subsidiaries of PlusAI;

enter into, assume, assign, amend or modify any material term of or terminate any employee collective bargaining contract of PlusAI or any of its subsidiaries, other than entry into such agreements in the ordinary course of business;

(1) issue, deliver, sell, transfer, pledge, dispose of or place any lien (other than a permitted lien) on any shares or any other equity or voting securities of PlusAI or any of its subsidiaries or (2) issue or grant any options, warrants, restricted stock units, SAFEs or other rights to purchase, convert into, exchange for or otherwise obtain any shares or any other equity or voting securities of PlusAI, or amend, modify or waive the terms of any of the foregoing, in each case other than (a) those issuances of PlusAI options or PlusAI RSUs disclosed in PlusAI’s disclosure letter to the Merger Agreement, in each case pursuant to 2017 Plan or 2021 Plan, as applicable, (b) issuances of shares of PlusAI common stock upon the exercise of PlusAI options, settlement of PlusAI RSUs, or the conversion of PlusAI SAFEs or PlusAI preferred stock, in each